Two Sigma Investments
TCRT icon

Two Sigma Investments’s Alaunos Therapeutics TCRT Stock Holding History

Two Sigma Investments’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$31K Sell
10,839
-7,749
-42% -$23.2K ﹤0.01% 4495
2025
Q4 		$60K Buy
+18,588
New +$60.1K ﹤0.01% 3915
2024
Q1 		– Sell
-2,010
Closed -$21.3K – 3384
2023
Q4 		$21.3K Sell
2,010
-51
-2% -$614 ﹤0.01% 3051
2023
Q3 		$40.8K Sell
2,061
-717
-26% -$30.9K ﹤0.01% 2832
2023
Q2 		$213K Sell
2,778
-3,762
-58% -$304K ﹤0.01% 2628
2023
Q1 		$618K Sell
6,540
-4,372
-40% -$416K ﹤0.01% 2108
2022
Q4 		$1.06M Buy
10,912
+8,066
+283% +$1.17M ﹤0.01% 1665
2022
Q3 		$734K Sell
2,846
-226
-7% -$65.6K ﹤0.01% 1598
2022
Q2 		$571K Sell
3,072
-8,812
-74% -$842K ﹤0.01% 1775
2022
Q1 		$1.16M Sell
11,884
-5,651
-32% -$725K ﹤0.01% 1642
2021
Q4 		$2.87M Buy
17,535
+14,498
+477% +$3.19M 0.01% 1608
2021
Q3 		$829K Sell
3,037
-2,462
-45% -$753K ﹤0.01% 2788
2021
Q2 		$2.18M Sell
5,499
-971
-15% -$453K ﹤0.01% 1786
2021
Q1 		$3.49M Buy
6,470
+764
+13% +$476K 0.01% 1289
2020
Q4 		$2.16M Buy
5,706
+589
+12% +$234K 0.01% 1448
2020
Q3 		$1.93M Buy
5,117
+5,005
+4,469% +$2.21M 0.01% 1312
2020
Q2 		$55K Sell
112
-2,870
-96% -$1.28M ﹤0.01% 2836
2020
Q1 		$1.1M Buy
2,982
+2,132
+251% +$1.1M 0.01% 1340
2019
Q4 		$602K Buy
850
+145
+21% +$99.8K ﹤0.01% 2639
2019
Q3 		$453K Buy
+705
New +$559K ﹤0.01% 2639
2019
Q1 		– Sell
-756
Closed -$212K – 3454
2018
Q4 		$212K Buy
+756
New +$299K ﹤0.01% 2679
2015
Q3 		– Sell
-460
Closed -$827K – 2713
2015
Q2 		$827K Sell
460
-1,472
-76% -$2.29M ﹤0.01% 1786
2015
Q1 		$3.12M Buy
+1,932
New +$2.86M 0.01% 940
2014
Q2 		– Sell
-217
Closed -$149K – 2346
2014
Q1 		$149K Buy
+217
New +$145K ﹤0.01% 1845

Other funds holding TCRT

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Two Sigma Investments's TCRT Position: Q1 2026 in Review

Two Sigma Investments reduced its Alaunos Therapeutics (TCRT) stake by 42% in Q1 2026, selling an estimated $23.2K and leaving 10,839 shares worth $31K. The position accounts for ﹤0.01% of the portfolio, ranked #4495.

Two Sigma Investments first reported a position in TCRT in Q1 2014 and has held it in 24 quarters since. The position peaked at $3.49M in Q1 2021. 29 funds tracked by Wall St. Rank hold TCRT as of Q1 2026.

  • Two Sigma Investments held 10,839 shares of Alaunos Therapeutics worth $31K as of Q1 2026.
  • Two Sigma Investments sold 7,749 Alaunos Therapeutics shares in Q1 2026, an estimated $23.2K.
  • Alaunos Therapeutics made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #4495 holding.
  • Two Sigma Investments first reported a position in Alaunos Therapeutics in Q1 2014 and has held it in 24 quarters since.
  • Two Sigma Investments's Alaunos Therapeutics position peaked at $3.49M in Q1 2021.
  • 29 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.